Vijay Sagar Madamsetty

13PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeuticsBiologically active moleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 29, 2025
Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma.

Vijay Sagar Madamsetty, Hari Krishnareddy Rachamala, Shamit Kumar Dutta

|Apr 13, 2024
Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma.

Emmanuel M Gabriel, Deborah Bahr, Hari Krishnareddy Rachamala

|Apr 19, 2022
Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems.

Vijay Sagar Madamsetty, Reza Mohammadinejad, Ilona Uzieliene

|Sep 16, 2021
LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells.

Ramcharan Singh Angom, Jian Zhu, Alexander T H Wu

|Aug 27, 2021
Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of KRAS.

Sneha Vivekanandhan, Vijay S Madamsetty, Ramcharan Singh Angom

|Jul 24, 2021
Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer.

Santosh Renuse, Vijay S Madamsetty, Dong-Gi Mun

Pageof 3

Frequent Collaborators

7 joint publications

Debabrata Mukhopadhyay

2 joint publications

Shima Tavakol

1 joint publications

Santosh Renuse

1 joint publications

Smrita Singh